{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T13:08:41Z","timestamp":1779455321201,"version":"3.53.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,22]]},"DOI":"10.7759\/cureus.109424","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:43:02Z","timestamp":1779453782000},"source":"Crossref","is-referenced-by-count":0,"title":["Metastatic Crohn\u2019s Disease and Acute Myeloid Leukemia: A Diagnostic Paradox in a Severe Hyperinflammatory State"],"prefix":"10.7759","author":[{"given":"Francisco David","family":"Roman Delgado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Carmen","family":"Rivera Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Missael Isaac","family":"Ruiz Godinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Elena","family":"Escorcia Saucedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Elivt","family":"De La Rosa Patlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Anda Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14447","article-title":"Metastatic Crohn's disease: an underestimated entity","volume":"19","author":"Ickrath F","year":"2021","unstructured":"Ickrath F, Stoevesandt J, Schulmeyer L, Glatzel C, Goebeler M, Kerstan A. Metastatic Crohn's disease: an underestimated entity. J Dtsch Dermatol Ges. 2021, 19:973-82. 10.1111\/ddg.14447","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2010.03.007","article-title":"Metastatic Crohn's disease (Article in Spanish)","volume":"33","author":"Romero Guti\u00e9rrez M","year":"2010","unstructured":"Romero Guti\u00e9rrez M, Alc\u00e1ntara Torres M, Mu\u00f1oz Rosas C, G\u00f3mez Moreno AZ, Guardiola Ar\u00e9valo A, Rodr\u00edguez Merlo R, Carrobles Jim\u00e9nez JM. Metastatic Crohn's disease (Article in Spanish). Gastroenterol Hepatol. 2010, 33:440-4. 10.1016\/j.gastrohep.2010.03.007","journal-title":"Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2019.02.002","article-title":"Myeloid disorders after autoimmune disease","volume":"32","author":"Boddu PC","year":"2019","unstructured":"Boddu PC, Zeidan AM. Myeloid disorders after autoimmune disease. Best Pract Res Clin Haematol. 2019, 32:74-88. 10.1016\/j.beha.2019.02.002","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1515\/medgen-2024-2008","article-title":"Overview on WHO-HAEM5 and the diagnostic relevance of genetic alterations for the classification","volume":"36","author":"Haferlach C","year":"2024","unstructured":"Haferlach C, Ott G, H\u00f6rst K, K\u00fchn C, Haferlach T, Siebert R. Overview on WHO-HAEM5 and the diagnostic relevance of genetic alterations for the classification. Med Genet. 2024, 36:3-11. 10.1515\/medgen-2024-2008","journal-title":"Med Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-0090-0","article-title":"Concurrent inflammatory bowel disease and myelodysplastic syndrome: report of nine new cases and a review of the literature","volume":"53","author":"Wang Z","year":"2008","unstructured":"Wang Z, Zhou Y, Liu Y. Concurrent inflammatory bowel disease and myelodysplastic syndrome: report of nine new cases and a review of the literature. Dig Dis Sci. 2008, 53:1929-32. 10.1007\/s10620-007-0090-0","journal-title":"Dig Dis Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkab096","article-title":"Associations of inflammatory bowel disease and subsequent cancers in a population-based study of older adults in the United States","volume":"6","author":"Wang JH","year":"2022","unstructured":"Wang JH, D'Arcy M, Barnes EL, Freedman ND, Engels EA, Song M. Associations of inflammatory bowel disease and subsequent cancers in a population-based study of older adults in the United States. JNCI Cancer Spectr. 2022, 6:10.1093\/jncics\/pkab096","journal-title":"JNCI Cancer Spectr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-006-9005-3","article-title":"TNF-alpha in promotion and progression of cancer","volume":"25","author":"Balkwill F","year":"2006","unstructured":"Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006, 25:409-16. 10.1007\/s10555-006-9005-3","journal-title":"Cancer Metastasis Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-203318","article-title":"Acute promyelocytic leukaemia (APL) in a patient with Crohn's disease and exposure to infliximab: a rare clinical presentation and review of the literature","volume":"2014","author":"Mohammad F","year":"2014","unstructured":"Mohammad F, Vivekanandarajah A, Haddad H, Shutty CM, Hurford MT, Dai Q. Acute promyelocytic leukaemia (APL) in a patient with Crohn's disease and exposure to infliximab: a rare clinical presentation and review of the literature. BMJ Case Rep. 2014, 2014:10.1136\/bcr-2013-203318","journal-title":"BMJ Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.77400","article-title":"B-cell acute lymphoblastic leukemia in a patient with Crohn's disease after anti-TNF-alpha treatment","volume":"17","author":"Kawtharani AA","year":"2025","unstructured":"Kawtharani AA, Akiki L, Rachid A, Geagea AS, Abi Abboud A. B-cell acute lymphoblastic leukemia in a patient with Crohn's disease after anti-TNF-alpha treatment. Cureus. 2025, 17:e77400. 10.7759\/cureus.77400","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz T","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006, 295:2275-85. 10.1001\/jama.295.19.2275","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06252-z","article-title":"Hemophagocytic lymphohistiocytosis occurring in inflammatory bowel disease: systematic review","volume":"66","author":"Coburn ES","year":"2021","unstructured":"Coburn ES, Siegel CA, Winter M, Shah ED. Hemophagocytic lymphohistiocytosis occurring in inflammatory bowel disease: systematic review. Dig Dis Sci. 2021, 66:843-54. 10.1007\/s10620-020-06252-z","journal-title":"Dig Dis Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2314005","article-title":"Hemophagocytic lymphohistiocytosis","volume":"392","author":"Henter JI","year":"2025","unstructured":"Henter JI. Hemophagocytic lymphohistiocytosis. N Engl J Med. 2025, 392:584-98. 10.1056\/NEJMra2314005","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet L","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, et al.. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014, 66:2613-20. 10.1002\/art.38690","journal-title":"Arthritis Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv141","article-title":"European evidence-based consensus: inflammatory bowel disease and malignancies","volume":"9","author":"Annese V","year":"2015","unstructured":"Annese V, Beaugerie L, Egan L, et al.. European evidence-based consensus: inflammatory bowel disease and malignancies. J Crohns Colitis. 2015, 9:945-65. 10.1093\/ecco-jcc\/jjv141","journal-title":"J Crohns Colitis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.2495-18","article-title":"Usefulness of ustekinumab for treating a case of myelodysplastic syndrome-associated inflammatory bowel disease","volume":"58","author":"Kono M","year":"2019","unstructured":"Kono M, Sakurai T, Okamoto K, et al.. Usefulness of ustekinumab for treating a case of myelodysplastic syndrome-associated inflammatory bowel disease. Intern Med. 2019, 58:2029-33. 10.2169\/internalmedicine.2495-18","journal-title":"Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2006.06.001","article-title":"Immunomodulation in myelodysplastic syndromes","volume":"19","author":"Sekeres MA","year":"2006","unstructured":"Sekeres MA, List A. Immunomodulation in myelodysplastic syndromes. Best Pract Res Clin Haematol. 2006, 19:757-67. 10.1016\/j.beha.2006.06.001","journal-title":"Best Pract Res Clin Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/494036-metastatic-crohns-disease-and-acute-myeloid-leukemia-a-diagnostic-paradox-in-a-severe-hyperinflammatory-state","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:43:03Z","timestamp":1779453783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/494036-metastatic-crohns-disease-and-acute-myeloid-leukemia-a-diagnostic-paradox-in-a-severe-hyperinflammatory-state"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.109424","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,22]]}}}